Los Angeles Capital Management
ANAB icon

Los Angeles Capital Management’s AnaptysBio ANAB Stock Holding History

Los Angeles Capital Management’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$869K Buy
15,664
+563
+4% +$30.3K ﹤0.01% 716
2025
Q4 		$551K Buy
15,101
+225
+2% +$8.77K ﹤0.01% 852
2025
Q3 		$456K Sell
14,876
-151
-1% -$3.46K ﹤0.01% 965
2025
Q2 		$334K Buy
+15,027
New +$315K ﹤0.01% 1009
2022
Q3 		– Sell
-20,783
Closed -$422K – 1218
2022
Q2 		$422K Sell
20,783
-84,828
-80% -$1.88M ﹤0.01% 1027
2022
Q1 		$2.61M Sell
105,611
-16,285
-13% -$493K 0.01% 472
2021
Q4 		$4.24M Sell
121,896
-8,664
-7% -$275K 0.02% 374
2021
Q3 		$3.54M Buy
130,560
+4,355
+3% +$111K 0.02% 400
2021
Q2 		$3.27M Buy
126,205
+50,175
+66% +$1.2M 0.01% 466
2021
Q1 		$1.64M Buy
76,030
+65,660
+633% +$1.66M 0.01% 685
2020
Q4 		$223K Sell
10,370
-11,650
-53% -$283K ﹤0.01% 1451
2020
Q3 		$325K Buy
22,020
+2,300
+12% +$41.5K ﹤0.01% 1243
2020
Q2 		$441K Buy
19,720
+8,170
+71% +$149K ﹤0.01% 1160
2020
Q1 		$163K Buy
+11,550
New +$175K ﹤0.01% 1225
2019
Q4 		– Sell
-12,470
Closed -$436K – 1264
2019
Q3 		$436K Hold
12,470
– – ﹤0.01% 1023
2019
Q2 		$704K Buy
12,470
+1,635
+15% +$118K ﹤0.01% 951
2019
Q1 		$791K Buy
10,835
+860
+9% +$59.4K ﹤0.01% 936
2018
Q4 		$636K Sell
9,975
-1,985
-17% -$148K ﹤0.01% 890
2018
Q3 		$1.19M Sell
11,960
-11,330
-49% -$940K 0.01% 808
2018
Q2 		$1.66M Buy
+23,290
New +$1.95M 0.01% 747

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Los Angeles Capital Management's ANAB Position: Q1 2026 in Review

Los Angeles Capital Management increased its AnaptysBio (ANAB) stake by 3.7% in Q1 2026, buying an estimated $30.3K and bringing the position to 15,664 shares worth $869K. The position accounts for ﹤0.01% of the portfolio, ranked #716.

Los Angeles Capital Management first reported a position in ANAB in Q2 2018 and has held it in 20 quarters since. The position peaked at $4.24M in Q4 2021. 207 funds tracked by Wall St. Rank hold ANAB as of Q1 2026.

  • Los Angeles Capital Management held 15,664 shares of AnaptysBio worth $869K as of Q1 2026.
  • Los Angeles Capital Management bought 563 AnaptysBio shares in Q1 2026, an estimated $30.3K.
  • AnaptysBio made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q1 2026, its #716 holding.
  • Los Angeles Capital Management first reported a position in AnaptysBio in Q2 2018 and has held it in 20 quarters since.
  • Los Angeles Capital Management's AnaptysBio position peaked at $4.24M in Q4 2021.
  • 207 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2026.

Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.